Senhwa Biosciences announces positive data from phase 1/expansion trial of Silmitasertib for basal cell carcinoma treatment: Taipei, Taiwan Thursday, April 3, 2025, 15:00 Hrs [IST ...

Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination with ...

Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination with chemotherapy in first-line pancreatic cancer - - Announced ...

The Polokwane-based winger Oswin Appollis said they have been putting the hard yard and he feels through the hard work they will secure a positive result. “You know, it’s going to be a tough game – ...

4 During 2024, investments of $10.1 billion formerly included in the Real-rate products were transferred to other investment strategies within Fixed income ($9.2 billion) and Credit ($0.9 billion).

Rich Wilson, President and Chief Executive Officer, commented, "We are pleased with the continued trend of same-store sales increases as September marks the eighth consecutive month of positive ...

Hoth Therapeutics (HOTH) announced breakthrough preclinical findings demonstrating the efficacy of HT-KIT, a novel targeted therapy for gastrointestinal stromal tumors. The results highlight HT ...

John Newlands, Develop North chair, said: “Although sentiment has dipped following the Budget, and businesses clearly face additional costs, we continue to have a positive outlook for 2025. “This view ...

The primary endpoint of the study was mean change from baseline in MG-ADL in acetylcholine receptor antibody positive (AChR+) participants at Week 12 (end of Period 1). The Phase 2b study in CIDP is a ...

It’s helpful in reducing positive symptoms of schizophrenia, especially treatment-resistant symptoms such as delusions. Positive symptoms are symptoms that are added to your current baseline ...